Phase I trial of KB 001 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2017
At a glance
- Drugs KB 001 (Primary)
- Indications Pseudomonal infections
- Focus Adverse reactions
- 07 Aug 2017 According to Humanigen media release, KaloBios Pharmaceuticals changed its name to Humanigen.
- 25 Jun 2007 New trial record.